Here’s what Chromadex Chairman Frank Jaksch said about NAD boosting supplement NMN (FAQs and Anecdotes) vs Nicotinamide Riboside “NR” (FAQs) (Anecdotes) on yesterday’s earnings call:

At the 10:56 mark:

“In reviewing the broader category of NAD precursors, a second clinical study on NMN was published in April in the journal Science entitled “Nicotinamide Mononucleotide (NMN) Increases Muscle Insulin Sensitivity in Prediabetic Women“.

We believe there’s a significant limitation with this study that calls into question the scientific validity of its conclusions — and we will follow up when appropriate.

NMN remains inferior to NR (Nicotinamide Riboside) across the board regarding published human science, regulatory approvals, and benefit to human health worldwide.”

You can listen to the entire earnings call HERE.

RELATED POST:

  • NMN vs NR — What Should You Do? (LINK)
  • FAQs on taking NAD boosting vitamin supplement Nicotinamide Riboside (NR) can be found HERE.
  • NR supplementation may have helped sufferers of these diseases & conditions (Consumer Reviews)

FOLLOW us on Twitter @RaisingNAD